Dr Divilly presenting data from HypoResolve showing the lack of overlap between sensor detected and person reported hypoglycaemia- highlighting importance of recording / reporting both Uffe Søholm 🌎 Advanced Technologies & Treatments for Diabetes Natalie Zaremba Bastiaan De Galan @#ATTD2023

FreeStyle Libre 2 and FreeStyle Libre 3 are FDA cleared to connect with automated insulin dosing systems in the U.S. Now that’s something to get pumped up about. 🙌 Learn more: abbo.tt/3SRASvk ISI: abbo.tt/3Cgi1kP

Imagine a doctor telling you they can delay your child's T1D diagnosis. That's what happened to one NC family. Their story this week: bit.ly/DiabetesCxns551 @ProventionBio Children's Hospital of Richmond at VCU #dmsa #T1D

BREAKING: The FDA announced a t1d stem cell therapy from Vertex has been cleared to enter clinical trials in the US. The therapy hopes to avoid the need for immunosuppressive drugs when replacing damaged insulin-producing cells in someone with t1d. More - bit.ly/422HgE8

SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant science.org/doi/10.1126/sc…

Viva TCOYD! You're invited to TCOYD's Virtual Diabetes Conference & Health Fair on April 15th. Get ready to ACE your diabetes by learning the right tricks & strategies to hit the jackpot of good diabetes health. We're betting on it! More information here: bit.ly/3mb8dFg

Shivani Misra on ketosis prone T2 diabetes: it's not just a lack of insulin but an excess of counter regulatory hormones too #IDS2023

SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant science.org/doi/10.1126/sc…@

In children 2 to younger than 6 years of age with type 1 diabetes, a closed-loop control system was associated with a greater percentage of time in the target glycemic range than standard care. nej.md/3ZYzedW #pediatrics #T1D

Dr. Edelman has been wearing his EversenseCGM E3 Implantable CGM for 6 weeks. Now here's ready to share his thoughts about the system. Learn more about his take on the accuracy, ease of use, comfort, and benefits of this CGM system. Learn more here: bit.ly/3ZAoPF2

Should we get our hopes up about Tzield? This week, I'm talking to one of the first doctors to administer this new treatment to delay the onset of #T1D. Children's Hospital of Richmond at VCU @ProventionBio bit.ly/DiabetesCxns558 #dmsa #diabetes

FDA Grants Clearance to iLet Bionic Pancreas hcplive.com/view/fda-grant… via yanina yaanina

Today, JDRF is celebrating Clinical Trials Day! Did you know there are currently over 100 actively recruiting studies for T1D in the U.S.? Clinical trials are essential for delivering new devices and treatments to people with T1D. (1 of2) youtube.com/watch?v=p9g-um…

The iLet Bionic Pancreas is said to be "Diabetes without numbers." Sounds great! How exactly does that work?! A deep-dive this week with Beta Bionics CEO Sean Saint bit.ly/DiabetesCxns570 #T1D #ilet #GoBionic

Ed Damiano, PhD, Founder and Executive Chairman at Beta Bionics, recently appeared on the Juicebox Podcast T1D. He spoke about our history, how the iLet Bionic Pancreas algorithms work, our commercial launch, and more. Listen at: bit.ly/iLetJuiceboxPo… #Diabetes #T1D #GoBionic

Tune in on Wednesday for a virtual broadcast overview of the ADA scientific sessions! This event will start at 4 pm PST / 7 pm EST and we will have a viewer Q&A!! #tcoyd #diatribe #diabetes #ADAscientificsessions #ADA

The Untethered Regimen: Embrace Freedom in Motion! #tcoyd #diabetes #pumps Read more about this here- bit.ly/444rkSu

Our newest new-onset study, JAKPOT T1D, is open and enrolling people ages 12-35 who have been clinically diagnosed with type 1 diabetes within three months. Learn more about the JAKPOT T1D study with the link in our bio or at TrialNet.org/jakpot

The blue circle is the global symbol for diabetes awareness. The circle represents totality, wholeness, unity 🌎. Blue reflects the sky that UNITES. We strive to unlock new insights, develop innovative therapies, and ultimately transform the landscape for individuals living T1D.

Volunteering for Research Studies x.com/i/broadcasts/1…